{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:01:38Z","timestamp":1787155298853,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014553","name":"Simon Spies Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006286","name":"Kongelig Hofbuntmager Aage Bangs Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006286","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001732","name":"Danmarks Grundforskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jid.2025.04.034","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T11:37:51Z","timestamp":1747741071000},"page":"3079-3088.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Oral Roflumilast Suppresses Proinflammatory Cytokine Signaling and Reduces CD4+ T-Cell and Neutrophil Infiltration in Psoriasis"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5597-1912","authenticated-orcid":false,"given":"Elena","family":"Baez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6156-6081","authenticated-orcid":false,"given":"Mette","family":"Gyldenl\u00f8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4610-5428","authenticated-orcid":false,"given":"Hakim","family":"Ben Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3161-6409","authenticated-orcid":false,"given":"Thomas","family":"Emmanuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4243-9535","authenticated-orcid":false,"given":"Jennifer Astrup","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4838-300X","authenticated-orcid":false,"given":"Simon Francis","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5506-1319","authenticated-orcid":false,"given":"Claus","family":"Zachariae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8257-1816","authenticated-orcid":false,"given":"Alexander","family":"Egeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4784-9680","authenticated-orcid":false,"given":"Lone","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1816-4508","authenticated-orcid":false,"given":"Lars","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5665-5212","authenticated-orcid":false,"given":"Claus","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2025.04.034_bib1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol"},{"key":"10.1016\/j.jid.2025.04.034_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2025.04.034_bib3","first-page":"83","article-title":"Key signaling pathways in psoriasis: recent insights from antipsoriatic therapeutics","volume":"11","author":"Ben Abdallah","year":"2021","journal-title":"Psoriasis (Auckl)"},{"issue":"204","key":"10.1016\/j.jid.2025.04.034_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/978-3-642-17969-3_15","article-title":"Phosphodiesterases as targets for modulating T-cell responses","author":"Bj\u00f8rgo","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jid.2025.04.034_bib5","first-page":"329","article-title":"The association between psoriasis and chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"159","author":"Brinch Hyttel","year":"2024","journal-title":"Ital J Dermatol Venerol"},{"key":"10.1016\/j.jid.2025.04.034_bib6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/cmi.2012.15","article-title":"New insights of T cells in the pathogenesis of psoriasis","volume":"9","author":"Cai","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jid.2025.04.034_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41423-023-00974-6","article-title":"The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention","volume":"20","author":"Cambier","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jid.2025.04.034_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jdermsci.2023.04.001","article-title":"Roflumilast enhances the melanogenesis and attenuates oxidative stress-triggered damage in melanocytes","volume":"110","author":"Chen","year":"2023","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jid.2025.04.034_bib9","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1136\/ard.2010.134825","article-title":"Phosphodiesterase 4 (PDE4) regulation of proinflammatory cytokine and chemokine release from rheumatoid synovial membrane","volume":"70","author":"Crilly","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2025.04.034_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/ced.12062","article-title":"Systemic methotrexate therapy for psoriasis: past, present and future","volume":"38","author":"Dogra","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2025.04.034_bib11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/jpet.116.232819","article-title":"Treatment of skin inflammation with Benzoxaborole phosphodiesterase inhibitors: selectivity, cellular activity, and effect on cytokines associated with skin inflammation and skin architecture changes","volume":"358","author":"Dong","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jid.2025.04.034_bib12","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/bjd.20602","article-title":"Complete clearance of severe plaque psoriasis with 24 weeks of oral Roflumilast therapy","volume":"185","author":"Egeberg","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.04.034_bib13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/dermatopathology9020011","article-title":"Quantification of immunohistochemically stained cells in skin biopsies","volume":"9","author":"Emmanuel","year":"2022","journal-title":"Dermatopathology (Basel)"},{"key":"10.1016\/j.jid.2025.04.034_bib14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrd3276","article-title":"Roflumilast [published correction appears in Nat Rev Drug Discov 2024;23:563]","volume":"9","author":"Fabbri","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jid.2025.04.034_bib15","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: a graphical gene-set enrichment tool for animals and plants","volume":"36","author":"Ge","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jid.2025.04.034_bib16","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2025.04.034_bib17","article-title":"Efficacy and safety of oral Roflumilast for moderate-to-severe psoriasis-a randomized controlled trial (PSORRO)","volume":"30","author":"Gyldenl\u00f8ve","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jid.2025.04.034_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaad.2024.02.036","article-title":"Effects of oral Roflumilast therapy on body weight and cardiometabolic parameters in patients with psoriasis - results from a randomized controlled trial (PSORRO)","volume":"91","author":"Gyldenl\u00f8ve","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.04.034_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jid.2025.04.034_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pupt.2010.03.011","article-title":"The preclinical pharmacology of Roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease","volume":"23","author":"Hatzelmann","year":"2010","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jid.2025.04.034_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/1346-8138.15596","article-title":"Pharmacodynamic analysis of apremilast in Japanese patients with moderate to severe psoriasis: results from a phase 2b randomized trial","volume":"48","author":"Imafuku","year":"2021","journal-title":"J Dermatol"},{"key":"10.1016\/j.jid.2025.04.034_bib22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.5483\/BMBRep.2014.47.2.014","article-title":"The pathophysiological role of dendritic cell subsets in psoriasis","volume":"47","author":"Kim","year":"2014","journal-title":"BMB Rep"},{"key":"10.1016\/j.jid.2025.04.034_bib23","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jama.2022.15632","article-title":"Effect of Roflumilast cream vs vehicle cream on chronic plaque psoriasis: the DERMIS-1 and DERMIS-2 randomized clinical trials","volume":"328","author":"Lebwohl","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jid.2025.04.034_bib24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa2000073","article-title":"Trial of Roflumilast cream for chronic plaque psoriasis","volume":"383","author":"Lebwohl","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jid.2025.04.034_bib25","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fphar.2018.01048","article-title":"Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases","volume":"9","author":"Li","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jid.2025.04.034_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkz114","article-title":"The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2025.04.034_bib27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.jid.2025.04.034_bib28","first-page":"21","article-title":"Phosphodiesterase-4 inhibition in psoriasis","volume":"11","author":"Milakovic","year":"2021","journal-title":"Psoriasis (Auckl)"},{"key":"10.1016\/j.jid.2025.04.034_bib29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bjd.19380","article-title":"Role of regulatory T cells in psoriasis pathogenesis and treatment","volume":"184","author":"Nussbaum","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.04.034_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jaad.2015.03.049","article-title":"Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of apremilast in Psoriasis [ESTEEM] 1)","volume":"73","author":"Papp","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.04.034_bib31","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4049\/immunohorizons.2000083","article-title":"IL-37 expression is downregulated in lesional psoriasis skin","volume":"4","author":"R\u00f8nholt","year":"2020","journal-title":"Immunohorizons"},{"key":"10.1016\/j.jid.2025.04.034_bib32","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jaad.2024.01.018","article-title":"A randomized, controlled pilot study of oral Roflumilast compared with intramuscular methotrexate for plaque and scalp psoriasis","volume":"90","author":"Saadi","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.04.034_bib33","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1476-5381.2009.00559.x","article-title":"Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis","volume":"159","author":"Schafer","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jid.2025.04.034_bib34","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"David: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2025.04.034_bib35","author":"Walsh"},{"key":"10.1016\/j.jid.2025.04.034_bib36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/1346-8138.15184","article-title":"Dendritic cells: the driver of psoriasis","volume":"47","author":"Wang","year":"2020","journal-title":"J Dermatol"},{"key":"10.1016\/j.jid.2025.04.034_bib37","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fimmu.2016.00222","article-title":"Molecular Mechanisms for cAMP-mediated immunoregulation in T cells - role of anchored protein kinase A signaling units","volume":"7","author":"Wehbi","year":"2016","journal-title":"Front Immunol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25004919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25004919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:24:52Z","timestamp":1778473492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X25004919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0022202X25004919"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2025.04.034","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Roflumilast Suppresses Proinflammatory Cytokine Signaling and Reduces CD4+ T-Cell and Neutrophil Infiltration in Psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2025.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}